Funded Projects
Michael’s Cause fundraising events include a Spring Dinner Dance Gala which plays host to over 800 attendees. An annual fall time Step for a Cure 5k Run and walk as well as being a sponsor in the TCS NYC Marathon. In addition, several other smaller community based events take place throughout the year.
10/7/2023
$13,896.00
United Access – Jared Garza Van – Accessible Van
10/5/2023
$25,000.00
Jett Foundation – Accessible Vans – Jett Giving Fund
9/23/2023
$269.99
Jesus Zeferinoprado – 7 foot ramp – Amazon
6/20/2023
$1,122.00
VE Ralph and Sons AED device Ryan Schultz
4/30/2023
$50,000.00
Cure Care Disease – Myotrim Project – Ohio State Univ
3/30/2023
$724.84
Global Industrial – UMASS Memorial Hosp – Weighted Chair Scale
3/21/2023
$4,499.00
Whill Accessible chair – Alysondra Bourbeau
2/28/2023
$22,750
Jason Celik – Accessible Van
2/20/2023
$2,500
Tanner Rico – Hospital Bed
1/2/2023
$100,000
UMASS Memorial Hospital Duchenne Clinic
1/2/2023
$18,855
Kasper and Daniel Holmes – Accessible Van
1/2/2023
$100,000.00
PPDM Cardiac Initiative
11/1/2022
$25,000.00
Mobility Works – Accessible Vans – Pietro Scarso
1/1/1999
$750.00
Hope for Gus -Nepal Homes for MD boys
8/16/2022
$13,800.00
Mobility Works – Accessible Vans – John Perrina
8/12/2022
$25,000.00
Jett Foundation – Accessible Vans – Jett Giving Fund
7/22/2022
$4,789.50
Pietro Scarso- Rifton Chair
6/2/22
$1,751.00
Omari Stennett – Scale
3/29/2022
$289.00
Pietro Scarso – Shower Buddy Chair
2/11/2022
$13,000.00
Jett Foundation – Spencer Family Van
2/11/2022
$50,000.00
Univ of Washington – Non Viral Gene Therapy – Myosana Theraputics
1/5/2022
$3,999.00
Pietro Scarso – Porto Mobility – Scooter for Mobility
12/28/2021
$50,000.00
Univ of Washington – Non Viral Gene Therapy – Myosana Theraputics
11/4/2021
$3,999.00
Ryan Schultz – Porto Mobility – Scooter for Mobilty
9/7/2021
$11,790.00
West Coast Sales Company – Tanner Rico -Accessible Van
8/31/2021
$2,994.00
Conner Curran – Ranger Quattro Scooter Mobility
8/1/2021
$14,995.00
Consolidated Medical Supply – Stair lift for Omari Stennett
7/29/2021
$23,000.00
Hunter Burk – Dodge Caravan Access Van
6/18/2021
$4,180.00
James Crudup – AC unit for 31 Year Old Jason
5/27/2021
$100,000.00
Casimir – DVA Development Program – Video Trial for Endpoints DMD
3/28/2021
$20,000
Ryan Schultz – Ramps for house and Dock.
12/28/2020
$100,000.00
Charley’s Fund – The Duchenne Program at UMass Medical School. Duchenne Clinic Funding
12/28/2020
$10,000.00
Jett Foundation – Funding for Accessible Van for the Keegan Moore – 12 years old Kyle, TX
11/8/2020
$11,333.00
Walking Strong – Accessible Van for Rickey Wheeler
9/4/2020
$10,000.00
MGH Institute of Health Professions – Elise Townsend, PhD, DPT, PCS. DMD Motor Outcomes Trajectories Project
8/22/2020
$10,500.00
Gibraltor Home Improvement – Accessible Ramp for Omari Stennett
5/21/2020
$5,500.00
Linda Medina – Funeral Expense for Son Jesus Garcia Medina
4/20/2020
$20,000.00
Team Joseph Corona Virus Relief Fund Marissa Penrod
3/3/2020
$15,484.00
Matthew DeRicci Abby Lifts Hoyer Lift
1/26/2020
$66,667.00
University of Missouri Gene Therapy Dr. Dongsen Duan Study of pathway for Gene Therapy
05/22/2019
$147,333
Of Mice and Measures, Casimir Video Scales, Electrical Imendance Myography. In Collaboration with Charley’s Find, Pietro’s Fight and Ryan’s Quest.
05/15/2018
$50,000
Quercetin – Dr. Josh Selsby University of Iowa: Effects of a Quercetin Cocktail.
12/27/2017
$30,000
DMD Therapeutics. Dr. Ron Berenson/Dr. Carlo Rago – OPG Eficacy Study
10/21/2017
$35,000
Team Joseph – Dr. John Lynn Jeffries. Phrixus Pharmaceuticals. Carmaseal
09/27/2017
$10,350
DMD Therapeutics. Dr. Ron Berenson/Dr. Carlo Rago – OPG Eficacy Study
09/20/2017
$24,840
University of Missouri OPG – Dr. Dongsheg Duau. OPG Confirmation Study – funding to Ryans Quest who paid Univ of Missouri
04/07/2017
$50,000
Montelukast University of Missouri – Montelukast. Dr.Donsheng Duan / Dr. Bob McDonald.
04/07/2017
$37,500
Kennedy Krieger Institute Myoblast Therapy – Myoblasts derived from IPSC’s. Dr. Kathryn Wagner
01/15/2017
$25,000
DMD Therapeutics – Osteoprotegerin. Dr. Ron Berenson / Dr. Carlo Rago.
08/08/2016
$15,000
Phrixus Pharmaceuticals – Carmeseal – Clinical Trial – for treatment of heart failure and respiratory dysfunction in DMD
08/04/2016
$100,000
DMD Therapeutics – Relaxin – Dr. Ronald Berenson. Anti-Fibrotic agent to help with fibrosis in treating Duchenne Muscular Dystrophy
04/15/2016
$15,000
Project Goldilocks: Jackson Laboratories – Better Mouse Model for Duchenne testing.
03/20/2016
$70,000
DDID 100108 Oteoprotegerin (OPG): Dr. Jerome Frenette – OPG Bone Protector rescues fast twitch muscles
12/14/2015
$40,000
DDID # 100084 – Seratonin Modulators in Zebra Fish – Dr Louis Kunkel (Boston Childrens) – Effects of Seratonin Modulators in Zebra Fish and Mice
10/01/2015
$10,000
Grant/Donation – Hugo W. Moser – Hugo H Moser Research Laboratory – Fund Dr Wagner Laboratory for research.
07/28/2015
$5,000
Treat NMD / Tact Review: Funding for Tact Review – Fund research for review committee on DMD research treatments
06/27/2015
$10,000
DDID # 100094 Plasma Micro RNA Profiling: Dr Julie Saba (Children’s Hospital and Research Center at Oakland – S1P Lyaselnibitor Pilot in MDX Mice
05/12/2015
$70,000
DDID 10096 Reveragen VBP15. This research project will be an alternative to commonly used glucocorticoids with less side effects.
03/08/2015
$50,000
DMD Therapeutics – Osteoprotegerin. Dr. Ron Berenson / Dr. Carlo Rago.
03/08/2015
$25,000
DMD Therapeutics – Osteoprotegerin. Dr. Ron Berenson / Dr. Carlo Rago.
11/6/2014
$70,000
Phase I/IIa Follistatin Gene Therapy Trial. Dr. Jerry Mendell, Director Center for Gene Therapy at Nationwide Children’s Hospital, Columbus Ohio. Gene therapy is revolutionary science in our continued fight for better treatments and a future cure for Duchenne.
10/9/2014
$20,000
Natural hormone study that has effects on muscle that may benefit patients with DMD. In animal studies it has been demonstrated to regenerate damaged skeletal muscle.
08/07/2014
$25,000
DDID #100087 – Suppressing the level of inflammation in the muscle – Keith Foster, University of Reading, UK
07/15/2014
$30,000
Halo Therapeutics: HT100 Phase 1/2, Anti Fibriotic agent for the treatment of Duchenne Muscular Dystrophy.
01/04/2014
$7,500
Natural hormone which has the ability to regenerate muscle, reduce scarring, and improve cardiac function
12/19/2013
$20,000
DDID #100077 Multicenter randomized double-blind dose titration phase II study in patients with Duchenne muscular dystrophy to evaluate the efficacy and the tolerability of the combinations of Ibuprofen and Isosorbide Dinitrate. Conducted by Emillio Clementi, MD Phd, professor of pharmacology, Department of Biomedical and Clinical Sciences, University of Milano-E.Medea Scientific Institute.
12/17/2013
$5,000
Assist in payment to O’Neill and Associates for their lobbying efforts to help further research in DMD.
11/08/2013
$15,000
DDID #100071 Quercetin – Determining the mechanisms whereby a Quercetin enriched diet interrupts disease process in DMD.
06/28/2013
$70,000
Halo Therapeutics: HT100 Phase 1/2, Anti Fibriotic agent for the treatment of Duchenne Muscular Dystrophy.
03/26/2013
$15,000
Hugo W. Moser Research Institute at Kennedy Kreiger for Duchenne Muscular Dystrophy Research
01/27/2013
$5,000
Superior Mouse Model for DMD drug development.
01/04/2013
$10,000
Measurement of in vivo respiratory and cardiac function during dietary enrichment in animal models of DMD.
01/04/2013
$5,000
Development of Dystrophin Independent Therapy for DMD.
06/22/2012
$10,000
Muscle regeneration available research available with compounds delivered as nutraceutical. Using an unbiased screen a genetic pathway was identified and associated compounds that regenerate muscle in Duchenne Muscular Dystrophy mouse and fly models. Funding will assist in furthering research in this area.
5/22/2012
$30,000
Preparation of the Anti-Fibrotic Halofuginone for use in a multi-center Phase II clinical trial. Halofuginone is an anti-fibrotic and muscle regeneration promoter. To date 1.1 million dollars has been funded to help this project get to phase II clinical trial.
04/06/2012
$5,500.00
The effects of Poloxamer-188 (Carmeseal) on cardiac and skeletal muscle function in MDX mice. Cardiac Function plays an important role in those affected by DMD. Funding will help further research with this drug to see hopeful benefit.
04/06/2012
$1,000
Duchenne Dashboard Phases V and VI. The Duchenne Dashboard allows foundations to co-identify co-understand and co-fund projects in order to conquer Duchenne Muscular Dystrophy. Funding in this area is necessary to maintain upgrades to the Dashboard.
$2300000
Total Funding
